| Date | Time | Source | Headline | Symbol | Company |
| 07/30/2004 | 8:15AM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Second Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/26/2004 | 8:30AM | PR Newswire (US) | Successful Completion of Study Comparing Exenatide to Insulin Glargine Results in Milestone Payment from Lilly to Amylin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/30/2004 | 8:30AM | PR Newswire (US) | New Drug Application for Exenatide Submitted to FDA for Type 2 Diabetes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/06/2004 | 11:00AM | PR Newswire (US) | Scientific Presentations of Exenatide Data Show Improvements in Glucose Control and Restored Insulin Response in People with Typ | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/05/2004 | 11:00AM | PR Newswire (US) | Late-Breaking Presentation of Exenatide Pivotal Studies Show Significant Improvements in Glucose Control With Associated Weight | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/03/2004 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/02/2004 | 5:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Data Presented at American Diabetes Association Annual Meeting | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/21/2004 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Acceptance of 17 Abstracts for Publication at the American Diabetes Association Annual Meeting | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/14/2004 | 4:31PM | PR Newswire (US) | Amylin Files Resale Registration Statement for Convertible Senior Notes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/13/2004 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Banc of America Securities Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/03/2004 | 5:01PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Annual Meeting of Stockholders Presentation | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2004 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals To Present At Morgan Stanley Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/28/2004 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals Reports First Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/21/2004 | 5:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast First Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/08/2004 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals to Co-promote Reliant Pharmaceuticals' Family of Cardiovascular Products | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/05/2004 | 7:45PM | PR Newswire (US) | Amylin Pharmaceuticals, Inc. Announces Exercise of Initial Purchasers' Option for Additional $25 Million of Convertible Senior N | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/31/2004 | 7:09PM | PR Newswire (US) | Amylin Pharmaceuticals, Inc. Announces Pricing Of Convertible Senior Notes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2004 | 4:03PM | PR Newswire (US) | Amylin Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2004 | 7:30AM | PR Newswire (US) | Amylin Pharmaceuticals Advances Clinical Pipeline in Diabetes and Obesity | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/27/2004 | 4:44PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/24/2004 | 9:40AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for YHOO, VRTX, LRCX, ZRAN, And AMLN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/24/2004 | 7:30AM | PR Newswire (US) | Amylin Pharmaceuticals Reports 2003 Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/19/2004 | 7:30AM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Year-End Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/12/2004 | 7:30AM | PR Newswire (US) | Amylin Pharmaceuticals to Present At Roth Capital Partners Growth Stock Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2004 | 7:30AM | PR Newswire (US) | Amylin Pharmaceuticals CEO to Provide Corporate Update at JPMorgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/09/2004 | 4:06PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/07/2004 | 4:45PM | PR Newswire (US) | Amylin Pharmaceuticals Withdraws Swiss Regulatory Application for SYMLIN(R) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/06/2004 | 7:30AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/19/2003 | 8:53PM | PR Newswire (US) | Amylin Pharmaceuticals Announces Informal Inquiry by the Securities and Exchange Commission | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/18/2003 | 4:15PM | PR Newswire (US) | Amylin and Lilly Announce Achievement of First Exenatide Development Milestones | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |